コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 l elements of 2'-O-methoxyethyl residues and locked nucleic acid.
2 time that it is possible to obtain LNA-like (Locked Nucleic Acid 1) binding affinity and biological a
3 loops, CNG repeats, dangling ends, inosines, locked nucleic acids, 2-hydroxyadenines and azobenzenes.
5 nse oligonucleotides composed exclusively of locked nucleic acids (all-LNAs) complementary to CUG rep
6 on duplexes containing targeted insertion of locked nucleic acid analogs and abasic lesions in either
8 2'-O-methyl oligonucleotide probes with LNA (locked nucleic acid) and 2,6-diaminopurine substitutions
9 (that express high levels of mir-29) with a locked-nucleic acid antagonist of mir-29b increased Mcl-
10 In the present study, we show that an 8-mer locked nucleic acid anti-miR-155 oligonucleotide targeti
11 , we observed that in vivo administration of locked nucleic acid anti-miR-181b retarded both the deve
15 ssion, but transfection with let-7f-specific locked nucleic acid anti-miRNA increased beta(2)AR expre
17 nous administration of an miR-26a inhibitor, locked nucleic acid-anti-miR-26a, increased SMAD1 expres
18 s9, or primary FLT3-ITD(+) AML samples using locked nucleic acid antisense inhibitors, results in an
19 PGDS transcript levels, the responses of the locked nucleic acid antisense oligo-treated animals from
21 ational evidence for an optimized, synthetic locked nucleic acid antisense oligonucleotide inhibitor
22 thesis by intracisternal administration of a locked nucleic acid antisense oligonucleotide to young-a
23 ock-down of survivin using EZN-3042, a novel locked nucleic acid antisense oligonucleotide, in combin
24 strategy targeting the SARS-CoV-2 RNA using locked nucleic acid antisense oligonucleotides (LNA ASOs
26 ver, in the medial amygdala of female mice, "locked nucleic acid" antisense (AS) oligonucleotides wit
27 njection of mice on a western-type diet with locked nucleic acid-antisense oligonucleotides results i
29 d a selective inhibitory PCR (siPCR) using a locked nucleic acid-based PCR blocker to selectively inh
33 ese results demonstrate the potential of the locked nucleic acid bases for nucleic acid design for su
37 Addition of an OMe G-clamp to a 12mer OMe-locked nucleic acid chimera maintained, but did not enha
38 real-time polymerase chain reaction based on locked nucleic acid-containing primers in 174 patients,
39 Pyrene-functionalized 2'-amino-alpha-L-LNAs (locked nucleic acids) display extraordinary affinity tow
41 d virus vectors and inhibited with antisense locked nucleic acid-GapmeRs to examine its function.
43 cal imaging is performed using high-affinity locked nucleic acid imaging probes that stably yet rever
44 ram syntheses of d- or l-nucleoside analogs, locked nucleic acids, iminonucleosides, and C2'- and C4'
48 cing anti-GAA duplex RNAs or single-stranded locked nucleic acids into patient-derived cells increase
49 tentiation by the gapmer ASOs was blunted by locked nucleic acid (LNA) and 2'-methoxyethyl (2'MOE) mo
50 difications such as constrained ethyl (cEt), locked nucleic acid (LNA) and 2'-O-methoxyethyl (2'-MOE)
52 formationally restricted nucleotides such as locked nucleic acid (LNA) are very popular as affinity-,
54 his focused library of MYCASOs incorporating locked nucleic acid (LNA) bases at the 5'- and 3'-ends,
57 stilbene donor-acceptor capped hairpin with locked nucleic acid (LNA) bases on the dynamics and effi
60 ntaining bicylic modifications (BNA) such as locked nucleic acid (LNA) designed to induce target RNA
62 f VR, and alteration of TERRA levels using a locked nucleic acid (LNA) GapmeR led to large nuclear VR
65 s study we show by in vivo administration of locked nucleic acid (LNA) inhibitors that suppression of
68 ning either 2'-O-methoxyethylribose (MOE) or locked nucleic acid (LNA) modifications were designed to
70 that the 2'-N-(pyren-1-yl)carbonyl-2'-amino locked nucleic acid (LNA) monomer X is a highly versatil
71 entary road controlled by affinity-enhancing locked nucleic acid (LNA) monomers and additional regula
72 formationally restricted nucleotides such as locked nucleic acid (LNA) monomers are used extensively
73 nd TC-motif TFOs modified with six different locked nucleic acid (LNA) monomers, i.e. conventional an
76 tural elements of 2'O-methoxyethyl (MOE) and locked nucleic acid (LNA) nucleosides yielded a series o
78 is, we investigate the use of functionalized locked nucleic acid (LNA) oligomers as biomolecular hand
79 hat antisense peptide nucleic acid (PNA) and locked nucleic acid (LNA) oligomers can bind key IRES se
85 331F variant in either 2'-O-Methyl (2'-OMe), locked nucleic acid (LNA) or 2'-O-methoxy ethyl (MOE) ch
87 rate detection of BRAF V600E variation using locked nucleic acid (LNA) probe-based droplet digital po
88 pography (DNA-PAINT), and the specificity of locked nucleic acid (LNA) probes for the in situ detecti
90 ntaining mutations at the targeted loci, and locked nucleic acid (LNA) probes were used to enhance th
94 nucleotide containing 7xOMe and 5x5-methyl C locked nucleic acid (LNA) residues, and a peptide nuclei
95 ose modifications (e.g. 4'-C-methylation and Locked Nucleic Acid (LNA) substitution) at specific posi
96 ibitors containing optimized PS patterns and locked nucleic acid (LNA) sugar modifications, we charac
100 nucleosides in unlocked nucleic acid (UNA), locked nucleic acid (LNA), or beta-l-RNA series was eval
101 hereas inhibition of the let-7 family with a locked nucleic acid (LNA)-anti-miR has the opposite effe
104 nhanced RIC exploits the stronger binding of locked nucleic acid (LNA)-containing oligo(dT) probes to
105 rmine lncRNA localization using biotinylated locked nucleic acid (LNA)-containing oligonucleotides wi
106 molecular beacons with DNA, RNA and combined locked nucleic acid (LNA)-DNA backbones can all detect m
107 s two spectrally distinguishable fluorescent locked nucleic acid (LNA)-DNA oligonucleotide probes to
108 amage in porcine cardiac tissues and whether locked nucleic acid (LNA)-modified anti-miR chemistries
109 herapeutic potential of 8-mer seed-targeting locked nucleic acid (LNA)-modified anti-miR oligonucleot
110 using an s.c.-delivered seed-targeting 8-mer locked nucleic acid (LNA)-modified antimiR (LNA-antimiR-
112 gets the liver-expressed miRNA-122 using the locked nucleic acid (LNA)-modified antisense oligonucleo
115 )-ribose, or 2'-O, 4'-C-methylene bridged or locked nucleic acid (LNA)-modified nucleotides show subs
116 t of chronically infected chimpanzees with a locked nucleic acid (LNA)-modified oligonucleotide (SPC3
117 essenger RNA (mRNA) in suspended cells using locked nucleic acid (LNA)-modified oligonucleotide probe
118 ded (FFPE) tissues and cultured cells, using locked nucleic acid (LNA)-modified oligonucleotides.
119 the IL-6-deficient (IL-6((-)/(-))) mice with locked nucleic acid (LNA)-modified phosphorothioate olig
120 emonstrate efficient delivery using a simple locked nucleic acid (LNA)-polymer conjugate that assembl
124 G)-labeled oligonucleotide probes containing locked nucleic acids (LNA) and 1-ethyl-3-(3-dimethylamin
127 combination of site-directed mutagenesis and locked nucleic acids (LNA) complementary to defined doma
128 ation of TD05 coupled with modification with locked nucleic acids (LNA) increased conformational stab
131 hemical modifications such as 2'-O-Me, 2'-F, locked nucleic acids (LNA), unlocked nucleic acids (UNA)
133 ng phosphorodiamidate morpholino oligomer or locked nucleic acids (LNA)/2'-OMe mixmers with different
134 that Hsp90 protein binds PS-ASOs containing locked-nucleic-acid (LNA) or constrained-ethyl-bicyclic-
135 species-specific electrochemical DNA probe (locked nucleic acid, LNA) was synthesized and implemente
136 Inhibition of miR-30 using complementary locked nucleic acids (LNA30bcd) in both human IECs and h
137 However, the recent additions to the field - locked nucleic acids (LNAs) and peptide nucleic acids (P
139 e the potential of novel antigens containing locked nucleic acids (LNAs) as targets for antibodies.
142 ioate antisense oligonucleotides (ASOs) with locked nucleic acids (LNAs) improve target affinity, RNa
145 breast cancers, and therapeutic delivery of locked nucleic acids (LNAs) targeting BCAR4 strongly sup
147 bility of oligonucleotides (ODNs) containing locked nucleic acids (LNAs) to bind supercoiled, double-
148 he most potent siRNA, siR-7, was modified by Locked nucleic acids (LNAs) to obtain siR-7-EM with incr
149 ctive targeting ss(ATTCC)(n) using antisense locked nucleic acids (LNAs), effectively disrupting NET-
151 d gain-of-function studies, using anti-sense locked-nucleic acids (LNAs) and synthetic RNA mimetics,
153 led miRNAs by next generation sequencing and locked nucleic acid miRNA microarrays and verified conco
155 of miR-21 through intravenous delivery of a locked nucleic acid-modified (LNA-modified) antimiR olig
158 Inhibition of miR-23 and miR-27 function by locked nucleic acid-modified anti-miRNAs represses angio
159 n of the miR-15 family in neonatal mice with locked nucleic acid-modified anti-miRNAs was associated
160 iac remodeling, our current study employed a locked nucleic acid-modified antimiR to target miR-378 i
164 cardiac mRNA for therapeutic purposes using locked nucleic acid-modified antisense oligonucleotides.
165 ction, and extracellular matrix genes, using locked nucleic acid-modified antisense TFIIB oligonucleo
168 diac disease models were administered with a locked nucleic acid-modified oligonucleotide (LNA-antimi
171 isense oligonucleotides (oligos), containing locked nucleic acid moieties (an improved technology), t
172 To optimize beacons for RT-LAMP, multiple locked nucleic acid monomers were incorporated to elevat
175 Kdm6b small interfering RNA or an antisense locked nucleic acid oligonucleotide specific to Arc eRNA
176 ibers, we blocked miR-210 with complementary locked nucleic acid oligonucleotides (anti-miR-210).
177 bilateral intraamygdala injections of OTR AS locked nucleic acid oligonucleotides several days before
178 ymine, is weakly hybridized to complementary locked nucleic acid or 2'-OMe RNA ONs that are also subs
179 2', 4'-bridged nucleic acids (also known as locked nucleic acid or LNA, and 2',4'-constrained ethyl
182 properties were optimized using 2'-O-methyl, locked nucleic acid, or phosphorodiamidate morpholino ba
183 es; and DNA backbone modifications including locked nucleic acids, peptide nucleic acids and borane n
185 paraffin-embedded tissues were hybridized to locked nucleic acid probes against 752 human miRNAs (rep
187 ned optimal hybridization parameters for 130 locked nucleic acid probes by recording nucleic acid mel
190 develop and validate a qPCR assay utilizing locked nucleic acid probes to detect different mitotypes
191 ombines the unique recognition properties of locked nucleic acid probes with enzyme-labeled fluoresce
194 cent in situ hybridization (flow-FISH) using locked-nucleic acid probes is combined with rolling circ
195 ilencing of miR-125b by systemic delivery of locked nucleic acid rescued angiotensin II-induced periv
196 T(L)AC(L)GA(L)CG(L)GC(L)C, with L denoting a locked nucleic acid residue, inhibit 50% of group I intr
197 Oligonucleotides composed of 2'-O-methyl and locked nucleic acid residues complementary to HIV-1 tran
198 ice, inhibition of miR-193a by complementary locked nucleic acids resulted in an upregulation of the
199 Control of ground-state conformation by the locked nucleic acids results in a marked increase in bot
202 inhibition of miR-30a-5p in the mPFC using a Locked Nucleic Acid sequence that targets miR-30a-5p res
203 reatment of PNET cells with Erk inhibitor or locked nucleic acids sequestering miR-431 inhibits invas
205 Purification protocols using oligo dT's, locked nucleic acid substituted dT's, and tetramethylamm
206 l agRNAs can contain 2'F-RNA, 2'OMe-RNA, and locked nucleic acid substitutions, or combinations of mu
209 titive antagonism of TLR8 with non-targeting locked nucleic acids was found to prevent native LDL-ind